Ali Ghaleiha
Ali Ghaleiha
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study
A Ghaleiha, N Entezari, A Modabbernia, B Najand, N Askari, M Tabrizi, ...
Journal of psychiatric research 47 (2), 175-180, 2013
Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia
A Modabbernia, F Rezaei, B Salehi, M Jafarinia, M Ashrafi, M Tabrizi, ...
CNS drugs 27 (1), 57-65, 2013
Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
A Ghaleiha, M Asadabadi, MR Mohammadi, M Shahei, M Tabrizi, ...
International Journal of Neuropsychopharmacology 16 (4), 783-789, 2013
Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double‐blind, placebo‐controlled trial
A Zeinoddini, M Sorayani, E Hassanzadeh, M Arbabi, M Farokhnia, ...
Depression and anxiety 32 (3), 167-173, 2015
Crocus sativus L. versus citalopram in the treatment of major depressive disorder with anxious distress: a double-blind, controlled clinical trial
A Ghajar, SM Neishabouri, N Velayati, L Jahangard, N Matinnia, ...
Pharmacopsychiatry 50 (04), 152-160, 2017
Training emotional intelligence improves both emotional intelligence and depressive symptoms in inpatients with borderline personality disorder and depression
L Jahangard, M Haghighi, H Bajoghli, M Ahmadpanah, A Ghaleiha, ...
International Journal of Psychiatry in Clinical Practice 16 (3), 197-204, 2012
Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double‐blind, placebo‐controlled trial
S Arabzadeh, N Ameli, A Zeinoddini, F Rezaei, M Farokhnia, ...
Bipolar disorders 17 (6), 606-614, 2015
Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial
A Ghaleiha, M Ghyasvand, MR Mohammadi, M Farokhnia, N Yadegari, ...
Journal of Psychopharmacology 28 (7), 677-685, 2014
In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder
L Jahangard, S Soroush, M Haghighi, A Ghaleiha, H Bajoghli, ...
European Neuropsychopharmacology 24 (8), 1210-1221, 2014
Double‐blind randomized parallel‐group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression
R Abolfazli, M Hosseini, A Ghanizadeh, A Ghaleiha, M Tabrizi, ...
Depression and anxiety 28 (4), 297-302, 2011
A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism
A Ghaleiha, SM Rasa, M Nikoo, M Farokhnia, MR Mohammadi, ...
Psychiatry research 229 (1-2), 181-187, 2015
Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial
A Ghaleiha, E Mohammadi, MR Mohammadi, M Farokhnia, ...
Pediatric Drugs 15 (6), 505-514, 2013
Assessing protective factors against drug abuse among high school students: Self-control and the extended parallel process model
H Allahverdipour, R MacIntyre, A Hidarnia, F Shafii, A Kzamnegad, ...
Journal of Addictions Nursing 18 (2), 65-73, 2007
Adjuvant thiamine improved standard treatment in patients with major depressive disorder: results from a randomized, double-blind, and placebo-controlled clinical trial
A Ghaleiha, H Davari, L Jahangard, M Haghighi, M Ahmadpanah, ...
European archives of psychiatry and clinical neuroscience 266 (8), 695-702, 2016
Minocycline as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind placebo-controlled trial
A Ghaleiha, R Alikhani, MR Kazemi, MR Mohammadi, ...
Journal of child and adolescent psychopharmacology 26 (9), 784-791, 2016
Riluzole in augmentation of fluvoxamine for moderate to severe obsessive–compulsive disorder: R andomized, double‐blind, placebo‐controlled study
S Emamzadehfard, A Kamaloo, K Paydary, A Ahmadipour, A Zeinoddini, ...
Psychiatry and clinical neurosciences 70 (8), 332-341, 2016
The prevalence of psychiatric distress and associated risk factors among college students using GHQ-28 questionnaire
J Poorolajal, A Ghaleiha, N Darvishi, S Daryaei, S Panahi
Iranian journal of public health 46 (7), 957, 2017
Acetyl-L-carnitine as an adjunctive therapy in the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a placebo-controlled trial
SH Abbasi, S Heidari, MR Mohammadi, M Tabrizi, A Ghaleiha, ...
Child Psychiatry & Human Development 42 (3), 367-375, 2011
Characteristics of hospitalized patients following suicide attempt in hamadan district, iran
A Ghaleiha, S Afzali, M Bazyar, F Khorsand, S Torabian
Oman medical journal 27 (4), 304, 2012
Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial
M Ghazizadeh-Hashemi, A Ghajar, MR Shalbafan, ...
Journal of affective disorders 232, 127-133, 2018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20